When was Apokyn approved by the FDA?

Written by Marisa Wexler, MS |

A

When was Apokyn approved by the FDA?

Category: Apokyn

The U.S. Food and Drug Administration approved Apokyn in 2004 as an add-on treatment for off periods in people with advanced Parkinson’s disease who are on levodopa-based treatments. The decision marked the first U.S. approval of a medication for off episodes in people with advanced disease.

Marisa Wexler, MS avatar

About the Author

Marisa Wexler, MS Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.


Recommended reading